Probing the Protective Role of EZH2 in Epilepsy
探讨 EZH2 在癫痫中的保护作用
基本信息
- 批准号:10617699
- 负责人:
- 金额:$ 50.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAccelerationAlzheimer&aposs DiseaseAmygdaloid structureAnticonvulsantsAntiepileptogenicAppearanceBindingBiochemicalBioinformaticsBlood - brain barrier anatomyBrainCell DeathCell NucleusCellsCellular AssayChIP-seqChromatinChronicComplexConvulsantsDataData SetDiseaseDisease ProgressionDoseEZH2 geneEpigenetic ProcessEpilepsyEpileptogenesisGene ExpressionGene SilencingGenerationsGenesGenetic ModelsGenetic TranscriptionHippocampusHistonesImmunohistochemistryIncidenceIndividualInflammationInstitutionLoxP-flanked alleleMeasuresMessenger RNAMethylationMethyltransferaseMigraineModelingMolecularMolecular BiologyMusNerve DegenerationNeuronsOutcome MeasureOutputPathologicPatientsPersonsPharmaceutical PreparationsPolycombPopulationProsencephalonProteinsPublishingRattusRecurrenceResectedRibosomesRoleSeizuresStatus EpilepticusStimulusTemporal Lobe EpilepsyTestingTimeTranscriptUp-RegulationWorkantagonistaxonal sproutingbioinformatics tooldravet syndromeexperimental studyfollow-upgene repressiongenetic approachgenetic corepressorgenome-widegranule cellinhibitorkainatemRNA Expressionnervous system disorderneurogenesisnovelpharmacologicpost strokeprogramsprotein complexresponsestoichiometrytranscription factortranscriptome sequencingvirtualwhole genome
项目摘要
Project Summary/Abstract
Epilepsy is the 4th most prevalent neurological disorder after stroke, Alzheimer’s and migraine with an
incidence of 1 in 26 individuals. Though there are a number of anti-convulsant drugs available, there are no
anti-epileptogenic drugs that mitigate the progression of the disease. Using novel bioinformatic approaches,
we have identified an endogenous, protective program launched by the brain after a prolonged seizure that
functions to mitigate pathological changes.
Epileptogenesis is associated with a plethora of changes in the brain including alterations in plasticity,
cell death, neurogenesis, inflammation and axonal sprouting. These changes occur over timescales ranging
from many minutes to years, but the orchestrating mechanisms are virtually unknown. Long-term changes in
gene expression that are associated with epileptogenesis imply that one or more master regulators of
transcription may be coordinating the brain alterations. In order to uncover these transcriptional mechanisms,
we turned to our recently published genome-wide expression datasets generated by the Epilepsy Microarray
Consortium (EMC). The datasets consist of mRNA expression profiles of rat dentate granule cells assayed at
various time points after Status Epilepticus (SE). Using a novel bioinformatic tool that integrates whole
genome transcription factor binding data with gene expression profiles, we analyzed datasets derived from
brains induced by 3 different convulsant stimuli, each in 2 independent labs, and at various time-points. This
analysis projected that Polycomb target genes represent the majority of chronically altered genes during
epileptogenesis. REST targets represent a second, overlapping, group of repressed genes. Polycomb is a
well-known driver of life-long changes in gene expression that works by epigenetically silencing genes across
the phyla. Our data shows an extremely robust induction of EZH2 protein (the catalytic methylase subunit of
Polycomb) over a 20 day window post SE in neurons. Further, we find that antagonizing EZH2 shortly after
SE robustly accelerates the onset of spontaneous recurrent seizures in mice, suggesting a protective rather
than pathological role for EZH2. How antagonism of EZH2 later after SE remains to be determined.
In this project, we will test the hypothesis that an alteration in Polycomb output is a principal modifier of
epileptogenesis. We will ascertain whether EZH2 upregulation is always protective or whether its role evolves
during the latent period. We will test the effect of an order-of-magnitude change in EZH2 levels on corepressor
function to see whether such upregulation augments or hampers the repressive abilities of two major EZH2
containing complexes: Polycomb and REST. We anticipate that these studies will establish Polycomb as
a major orchestrator of the long-term changes associated with epileptogenesis. If so, approaches that
modulate Polycomb function may be of benefit to the 65 million people world-wide that live with
epilepsy.
项目总结/摘要
癫痫是继中风、阿尔茨海默病和偏头痛之后第四大最常见的神经系统疾病,
发病率为1/26。虽然有一些抗惊厥药物,但没有
抗癫痫药物,减缓疾病的进展。使用新的生物信息学方法,
我们已经确定了长时间癫痫发作后大脑启动的一种内源性保护程序,
减轻病理变化的功能。
癫痫发生与大脑的大量变化有关,包括可塑性的改变,
细胞死亡、神经发生、炎症和轴突发芽。这些变化发生的时间范围
从几分钟到几年,但协调机制几乎是未知的。的长期变化
与癫痫发生相关的基因表达暗示一个或多个癫痫的主调节因子,
转录可能是协调大脑的变化。为了揭示这些转录机制,
我们转向我们最近发表的癫痫微阵列产生的全基因组表达数据集,
Consortium(EMC).数据集由在以下条件下测定的大鼠齿状颗粒细胞mRNA表达谱组成
癫痫持续状态(SE)后的不同时间点。使用一种新的生物信息学工具,
基因组转录因子结合数据与基因表达谱,我们分析了来自
由3种不同的惊厥刺激诱导的大脑,每种在2个独立的实验室中,在不同的时间点。这
分析预测,Polycomb靶基因代表了大多数慢性改变的基因,
癫痫发生REST靶标代表了第二组重叠的受抑制基因。Polycomb是一个
基因表达终身变化的众所周知的驱动因素,通过表观遗传学沉默基因来起作用。
门我们的数据显示了EZH 2蛋白(EZH 2蛋白的催化甲基化酶亚基)的极其稳健的诱导。
Polycomb)在神经元中SE后20天窗口内的变化。此外,我们发现,拮抗EZH 2后不久,
SE强烈地加速小鼠自发性复发性癫痫发作,这表明其具有保护作用,
而不是病理作用。SE后EZH 2的拮抗作用如何仍有待确定。
在这个项目中,我们将测试一个假设,即改变Polycomb输出是一个主要的修改器,
癫痫发生我们将确定EZH 2上调是否总是保护性的,或者它的作用是否会演变。
在潜伏期。我们将测试EZH 2水平的数量级变化对辅阻遏物的影响。
功能,以了解这种上调是否增强或阻碍两种主要EZH 2的抑制能力。
包含复合物:Polycomb和REST。我们预计,这些研究将建立Polycomb作为
癫痫发生相关的长期变化的主要协调者。如果是这样,
调节Polycomb功能可能对全世界6500万患有
癫痫
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
MAGIC: A tool for predicting transcription factors and cofactors driving gene sets using ENCODE data.
MAGIC:使用 ENCODE 数据预测驱动基因集的转录因子和辅助因子的工具。
- DOI:10.1371/journal.pcbi.1007800
- 发表时间:2020
- 期刊:
- 影响因子:4.3
- 作者:Roopra,Avtar
- 通讯作者:Roopra,Avtar
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAYMOND J DINGLEDINE其他文献
RAYMOND J DINGLEDINE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAYMOND J DINGLEDINE', 18)}}的其他基金
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits
针对癫痫发作后认知缺陷的 EP2 拮抗剂的优化
- 批准号:
10467539 - 财政年份:2022
- 资助金额:
$ 50.7万 - 项目类别:
Optimization of EP2 Antagonists for Post-Seizure Cognitive Deficits
针对癫痫发作后认知缺陷的 EP2 拮抗剂的优化
- 批准号:
10732636 - 财政年份:2022
- 资助金额:
$ 50.7万 - 项目类别:
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
利用 EP2 受体生物学选择性地靶向癫痫相关的神经炎症
- 批准号:
10356163 - 财政年份:2020
- 资助金额:
$ 50.7万 - 项目类别:
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
利用 EP2 受体生物学选择性地靶向癫痫相关的神经炎症
- 批准号:
10171930 - 财政年份:2020
- 资助金额:
$ 50.7万 - 项目类别:
Exploiting EP2 receptor biology to target seizure-related neuroinflammation selectively
利用 EP2 受体生物学选择性地靶向癫痫相关的神经炎症
- 批准号:
10570244 - 财政年份:2020
- 资助金额:
$ 50.7万 - 项目类别:
Probing the Protective Role of EZH2 in Epilepsy
探讨 EZH2 在癫痫中的保护作用
- 批准号:
10398140 - 财政年份:2019
- 资助金额:
$ 50.7万 - 项目类别:
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures
癫痫发作后血脑屏障完整性和癫痫发生的炎症控制
- 批准号:
9272954 - 财政年份:2016
- 资助金额:
$ 50.7万 - 项目类别:
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures
癫痫发作后血脑屏障完整性和癫痫发生的炎症控制
- 批准号:
9914359 - 财政年份:2016
- 资助金额:
$ 50.7万 - 项目类别:
Inflammatory control of blood-brain barrier integrity and epileptogenesis after seizures
癫痫发作后血脑屏障完整性和癫痫发生的炎症控制
- 批准号:
9159612 - 财政年份:2016
- 资助金额:
$ 50.7万 - 项目类别:
Regulation of epileptogenesis by the transcriptional repressor, REST
转录抑制因子 REST 对癫痫发生的调节
- 批准号:
8325008 - 财政年份:2011
- 资助金额:
$ 50.7万 - 项目类别:
相似海外基金
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 50.7万 - 项目类别:
Research Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 50.7万 - 项目类别:
Continuing Grant
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 50.7万 - 项目类别:
Standard Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 50.7万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 50.7万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 50.7万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 50.7万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 50.7万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 50.7万 - 项目类别:
Continuing Grant
Study of the Particle Acceleration and Transport in PWN through X-ray Spectro-polarimetry and GeV Gamma-ray Observtions
通过 X 射线光谱偏振法和 GeV 伽马射线观测研究 PWN 中的粒子加速和输运
- 批准号:
23H01186 - 财政年份:2023
- 资助金额:
$ 50.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)